| Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma (NCT04214392) | City of Hope Medical Center | 2020-02-26 |
| Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer (NCT03804164) | City of Hope Medical Center | 2020-02-10 |
| Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia (NCT04262843) | City of Hope Medical Center | 2020-02-07 |
| Perioperative Ostomy Self-Management Telehealth for Cancer Patients and Family Caregivers (NCT03970070) | City of Hope Medical Center | 2020-01-23 |
| Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery (NCT05203627) | City of Hope Medical Center | 2020-01-21 |
| Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma (NCT04200443) | City of Hope Medical Center | 2020-01-14 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913) | City of Hope Medical Center | 2019-12-24 |
| Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation (NCT03728335) | City of Hope Medical Center | 2019-12-23 |
| 68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer (NCT04216134) | City of Hope Medical Center | 2019-12-12 |
| Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma (NCT03952832) | City of Hope Medical Center | 2019-12-11 |
| IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM (NCT04003649) | City of Hope Medical Center | 2019-12-02 |
| Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT04060277) | City of Hope Medical Center | 2019-11-27 |
| PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer (NCT03873805) | City of Hope Medical Center | 2019-08-20 |
| Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia (NCT03512405) | City of Hope Medical Center | 2019-08-02 |
| Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT03346135) | City of Hope Medical Center | 2019-07-17 |
| Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma (NCT03884998) | City of Hope Medical Center | 2019-07-10 |
| Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes (NCT03746769) | City of Hope Medical Center | 2019-07-07 |
| IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer (NCT03655002) | City of Hope Medical Center | 2019-05-17 |
| CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer (NCT03829111) | City of Hope Medical Center | 2019-05-14 |
| CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma (NCT03710421) | City of Hope Medical Center | 2019-04-23 |
| Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related Lymphedema (NCT04465253) | City of Hope Medical Center | 2019-04-19 |
| IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer (NCT03918499) | City of Hope Medical Center | 2019-04-19 |
| CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant (NCT03922035) | City of Hope Medical Center | 2019-04-18 |
| Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers (NCT03902535) | City of Hope Medical Center | 2019-03-08 |
| Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer (NCT03853707) | City of Hope Medical Center | 2019-03-04 |
| Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease (NCT03865992) | City of Hope Medical Center | 2019-03-04 |
| Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas (NCT03373305) | City of Hope Medical Center | 2019-03-01 |
| Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998) | City of Hope Medical Center | 2019-02-04 |
| Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy (NCT03671811) | City of Hope Medical Center | 2019-01-21 |
| A Blood Stem Cell Transplant for Sickle Cell Disease (NCT03249831) | City of Hope Medical Center | 2019-01-04 |
| Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT03531281) | City of Hope Medical Center | 2018-12-30 |
| Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma (NCT03523975) | City of Hope Medical Center | 2018-12-24 |
| Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT03438344) | City of Hope Medical Center | 2018-12-01 |
| Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma (NCT03712202) | City of Hope Medical Center | 2018-11-28 |
| HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases (NCT03696030) | City of Hope Medical Center | 2018-11-27 |
| Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer (NCT03776253) | City of Hope Medical Center | 2018-11-15 |
| Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant (NCT04160390) | City of Hope Medical Center | 2018-11-13 |
| Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations (NCT04160429) | City of Hope Medical Center | 2018-11-09 |
| Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients (NCT03686007) | City of Hope Medical Center | 2018-11-06 |
| Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia (NCT03591744) | City of Hope Medical Center | 2018-10-25 |
| Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery (NCT03997162) | City of Hope Medical Center | 2018-10-11 |
| Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer (NCT06490159) | City of Hope Medical Center | 2018-10-01 |
| Predicting the Efficacy in Advanced Gastric Cancer. (NCT06490055) | City of Hope Medical Center | 2018-10-01 |
| ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT03402880) | City of Hope Medical Center | 2018-10-01 |
| Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy (NCT03661437) | City of Hope Medical Center | 2018-09-24 |
| Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease (NCT03664830) | City of Hope Medical Center | 2018-09-19 |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer (NCT03361735) | City of Hope Medical Center | 2018-08-29 |
| Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma (NCT03534180) | City of Hope Medical Center | 2018-08-21 |
| CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant (NCT03560752) | City of Hope Medical Center | 2018-08-20 |
| Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma (NCT03389230) | City of Hope Medical Center | 2018-08-14 |
| Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03494569) | City of Hope Medical Center | 2018-07-06 |
| Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer (NCT03592407) | City of Hope Medical Center | 2018-07-01 |
| Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer (NCT03477396) | City of Hope Medical Center | 2018-06-14 |
| Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant (NCT03354728) | City of Hope Medical Center | 2018-05-11 |
| Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma (NCT03479268) | City of Hope Medical Center | 2018-04-27 |
| Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery (NCT03317119) | City of Hope Medical Center | 2018-04-11 |
| Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma (NCT03440567) | City of Hope Medical Center | 2018-04-02 |
| Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities (NCT05414396) | City of Hope Medical Center | 2018-03-20 |
| Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia (NCT03467386) | City of Hope Medical Center | 2018-03-19 |
| Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma (NCT03311828) | City of Hope Medical Center | 2018-02-21 |
| Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy (NCT03422731) | City of Hope Medical Center | 2018-02-15 |
| Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease (NCT03279094) | City of Hope Medical Center | 2018-02-02 |
| P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03113487) | City of Hope Medical Center | 2018-02-01 |
| Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma (NCT03100877) | City of Hope Medical Center | 2018-01-01 |
| Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers (NCT03267524) | City of Hope Medical Center | 2017-11-09 |
| Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients (NCT03303846) | City of Hope Medical Center | 2017-10-13 |
| High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma (NCT03178617) | City of Hope Medical Center | 2017-10-12 |
| Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia (NCT02948283) | City of Hope Medical Center | 2017-09-05 |
| Comic Art Creation as Supportive Care in Cancer Patients and Caregivers (NCT03067766) | City of Hope Medical Center | 2017-08-24 |
| Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia (NCT03009240) | City of Hope Medical Center | 2017-08-21 |
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention (NCT02295059) | City of Hope Medical Center | 2017-08-09 |
| Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer (NCT04014231) | City of Hope Medical Center | 2017-07-21 |
| Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. (NCT03150329) | City of Hope Medical Center | 2017-07-18 |
| Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver (NCT03005002) | City of Hope Medical Center | 2017-06-28 |
| Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis (NCT03118492) | City of Hope Medical Center | 2017-06-21 |
| Education as an Intervention of Compassion Fatigue (NCT03212417) | City of Hope Medical Center | 2017-06-06 |
| Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer (NCT02971761) | City of Hope Medical Center | 2017-06-01 |
| High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant (NCT03128359) | City of Hope Medical Center | 2017-05-30 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma (NCT03113500) | City of Hope Medical Center | 2017-05-25 |
| Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT03013933) | City of Hope Medical Center | 2017-05-03 |
| Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors (NCT03063918) | City of Hope Medical Center | 2017-04-28 |
| Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL (NCT03016871) | City of Hope Medical Center | 2017-04-24 |
| Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma (NCT03057795) | City of Hope Medical Center | 2017-04-03 |
| Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer (NCT02996825) | City of Hope Medical Center | 2017-03-22 |
| Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma (NCT03011814) | City of Hope Medical Center | 2017-03-08 |
| Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease (NCT03007238) | City of Hope Medical Center | 2017-01-18 |
| Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer (NCT02673398) | City of Hope Medical Center | 2016-12-02 |
| Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery (NCT03117855) | City of Hope Medical Center | 2016-12-01 |
| Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis (NCT02917096) | City of Hope Medical Center | 2016-11-13 |
| Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor (NCT02944617) | City of Hope Medical Center | 2016-11-11 |
| Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer (NCT02830594) | City of Hope Medical Center | 2016-10-05 |
| Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer (NCT02778685) | City of Hope Medical Center | 2016-09-30 |
| An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients (NCT02878980) | City of Hope Medical Center | 2016-09-02 |
| Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer (NCT02827877) | City of Hope Medical Center | 2016-07-15 |
| Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT02744612) | City of Hope Medical Center | 2016-06-20 |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy (NCT02432963) | City of Hope Medical Center | 2016-06-14 |
| RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists (NCT02112565) | City of Hope Medical Center | 2016-06-13 |
| Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities (NCT02513407) | City of Hope Medical Center | 2016-04-06 |
| Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas (NCT02192359) | City of Hope Medical Center | 2016-04-05 |
| Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer (NCT02648477) | City of Hope Medical Center | 2016-03-28 |